Obtaining a medication to market in Australia, even a non-prescription a single, necessitates in depth investigation and expense. It would be too much for little cannabis producers to tackle, and also a turn-off for large pharmaceutical organizations if that financial commitment is on the expenditure of future blockbuster prescription drugs.Ash Ric